The Epstein-Barr virus (EBV) nuclear antigen-1 (EBNA1) maintains the viral episome in all host cells infected with EBV. Recently, EBNA1 was found to be the main EBV latency antigen for CD4+ T cells and could be recognized in cultures from all donors tested. We now identify a polarized Th1 phenotype and obtain evidence for its presence in vivo. When T cells were stimulated with dendritic cells infected with vaccinia vectors expressing EBNA1, 18 of 19 donors secreted IFN-γ, whereas only two of 19 secreted IL-4. Magnetic selection was then used to isolate cells from fresh blood based on EBNA1-induced cytokine production. Specific IFN-γ CD4+ cell lines were established from six of six donors and IL-4 lines from three of six. Only the Th1 lines specifically lysed targets expressing three different sources of EBNA1 protein. When the IgG isotype of EBNA1 plasma Ab’s was tested, most specific Ab’s were IgG1 and of a high titer, confirming a Th1 response to EBNA1 in vivo. Ab’s to other microbial antigens generally were not skewed toward IgG1. Given emerging evidence that Th1 CD4+ T cells have several critical roles in host defense to viral infection and tumors, we propose that EBNA1-specific CD4+ Th1 cells contribute to resistance to EBV and EBV-associated malignancies.
Kara Bickham, Christian Münz, Ming Li Tsang, Marie Larsson, Jean-Francois Fonteneau, Nina Bhardwaj, Ralph Steinman
Title and authors | Publication | Year |
---|---|---|
mRNA-based Vaccines Targeting the T-cell Epitope-rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti-Tumor Immunity in Mice.
Zhao GX, Bu GL, Liu GF, Kong XW, Sun C, Li ZQ, Dai DL, Sun HX, Kang YF, Feng GK, Zhong Q, Zeng MS |
2023 | |
Circulating T follicular helper 2 cells, T follicular regulatory cells and regulatory B cells are effective biomarkers for predicting the response to house dust mite sublingual immunotherapy in patients with allergic respiratory diseases
Shigehara K, Kamekura R, Ikegami I, Sakamoto H, Yanagi M, Kamiya S, Kodama K, Asai Y, Miyajima S, Nishikiori H, Uno E, Yamamoto K, Takano K, Chiba H, Ohnishi H, Ichimiya S |
Frontiers in immunology | 2023 |
Epstein–Barr virus and multiple sclerosis
Soldan SS, Lieberman PM |
Nature reviews. Microbiology | 2022 |
Combining Antivirals and Immunomodulators to Fight COVID-19
V Feuillet, B Canard, A Trautmann |
Trends in Immunology | 2021 |
Immunophenotypic characterization of TCR γδ T cells and MAIT cells in HIV-infected individuals developing Hodgkin’s lymphoma
CK Muller, J Spagnuolo, A Audigé, A Chancellor, D Russenberger, AU Scherrer, M Hoffmann, R Kouyos, M Battegay, GD Libero, RF Speck |
Infectious agents and cancer | 2021 |
Burkitt lymphoma with a granulomatous reaction: an M1/Th1‐polarised microenvironment is associated with controlled growth and spontaneous regression
M Granai, S Lazzi, V Mancini, A Akarca, R Santi, F Vergoni, E Sorrentino, R Guazzo, L Mundo, G Cevenini, C Tripodo, GD Stefano, B Puccini, M Ponzoni, E Sabattini, C Agostinelli, N Bassüllü, T Tecimer, AS Demiroz, L Mnango, S Dirnhofer, L QuintanillaMartinez, T Marafioti, F Fend, L Leoncini |
Histopathology | 2021 |
Variances in Antiviral Memory T-Cell Repertoire of CD45RA- and CD62L-Depleted Lymphocyte Products Reflect the Need of Individual T-Cell Selection Strategies to Reduce the Risk of GvHD while Preserving Antiviral Immunity in Adoptive T-Cell Therapy
Mangare C, Tischer-Zimmermann S, Bonifacius A, Riese SB, Dragon AC, Blasczyk R, Maecker-Kolhoff B, Eiz-Vesper B |
Transfusion Medicine and Hemotherapy | 2021 |
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition).
Cossarizza A, Chang HD, Radbruch A, Abrignani S, Addo R, Akdis M, Andrä I, Andreata F, Annunziato F, Arranz E, Bacher P, Bari S, Barnaba V, Barros-Martins J, Baumjohann D, Beccaria CG, Bernardo D, Boardman DA, Borger J, Böttcher C, Brockmann L, Burns M, Busch DH, Cameron G, Cammarata I, Cassotta A, Chang Y, Chirdo FG, Christakou E, Čičin-Šain L, Cook L, Corbett AJ, Cornelis R, Cosmi L, Davey MS, De Biasi S, De Simone G, Del Zotto G, Delacher M, Di Rosa F, Di Santo J, Diefenbach A, Dong J, Dörner T, Dress RJ, Dutertre CA, Eckle SBG, Eede P, Evrard M, Falk CS, Feuerer M, Fillatreau S, Fiz-Lopez A, Follo M, Foulds GA, Fröbel J, Gagliani N, Galletti G, Gangaev A, Garbi N, Garrote JA, Geginat J, Gherardin NA, Gibellini L, Ginhoux F, Godfrey DI, Gruarin P, Haftmann C, Hansmann L, Harpur CM, Hayday AC, Heine G, Hernández DC, Herrmann M, Hoelsken O, Huang Q, Huber S, Huber JE, Huehn J, Hundemer M, Hwang WYK, Iannacone M, Ivison SM, Jäck HM, Jani PK, Keller B, Kessler N, Ketelaars S, Knop L, Knopf J, Koay HF, Kobow K, Kriegsmann K, Kristyanto H, Krueger A, Kuehne JF, Kunze-Schumacher H, Kvistborg P, Kwok I, Latorre D, Lenz D, Levings MK, Lino AC, Liotta F, Long HM, Lugli E, MacDonald KN, Maggi L, Maini MK, Mair F, Manta C, Manz RA, Mashreghi MF, Mazzoni A, McCluskey J, Mei HE, Melchers F, Melzer S, Mielenz D, Monin L, Moretta L, Multhoff G, Muñoz LE, Muñoz-Ruiz M, Muscate F, Natalini A, Neumann K, Ng LG, Niedobitek A, Niemz J, Almeida LN, Notarbartolo S, Ostendorf L, Pallett LJ, Patel AA, Percin GI, Peruzzi G, Pinti M, Pockley AG, Pracht K, Prinz I, Pujol-Autonell I, Pulvirenti N, Quatrini L, Quinn KM, Radbruch H, Rhys H, Rodrigo MB, Romagnani C, Saggau C, Sakaguchi S, Sallusto F, Sanderink L, Sandrock I, Schauer C, Scheffold A, Scherer HU, Schiemann M, Schildberg FA, Schober K, Schoen J, Schuh W, Schüler T, Schulz AR, Schulz S, Schulze J, Simonetti S, Singh J, Sitnik KM, Stark R, Starossom S, Stehle C, Szelinski F, Tan L, Tarnok A, Tornack J, Tree TIM, van Beek JJP, van de Veen W, van Gisbergen K, Vasco C, Verheyden NA, von Borstel A, Ward-Hartstonge KA, Warnatz K, Waskow C, Wiedemann A, Wilharm A, Wing J, Wirz O, Wittner J, Yang JHM, Yang J |
European Journal of Immunology | 2021 |
Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals
P Shindiapina, EH Ahmed, A Mozhenkova, T Abebe, RA Baiocchi |
Frontiers in Oncology | 2020 |
Prognostic Significance of Granuloma and Amyloid Deposition in Nasopharyngeal Carcinoma
YC Lee, LY Lee, NM Tsang, CL Hsu, LJ Hsin, T Kuo, KP Chang |
Head and Neck Pathology | 2020 |
Infection and immune control of human oncogenic γ-herpesviruses in humanized mice
D McHugh, N Caduff, A Murer, C Engelmann, Y Deng, H Zdimerova, K Zens, O Chijioke, C Münz |
Philosophical Transactions of the Royal Society B: Biological Sciences | 2019 |
Correction: Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases
G Luo, L Lin, L Jacob, M Bonvalet, A Ambati, G Plazzi, F Pizza, R Leib, CM Adams, M Partinen, EJ Mignot |
PloS one | 2019 |
Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4 + T Cells
BJ Meckiff, K Ladell, JE McLaren, GB Ryan, AM Leese, EA James, DA Price, HM Long |
Journal of immunology (Baltimore, Md. : 1950) | 2019 |
Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice
DG van Zyl, MH Tsai, A Shumilov, V Schneidt, R Poirey, B Schlehe, H Fluhr, J Mautner, HJ Delecluse, R Khanna |
PLoS pathogens | 2018 |
CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors
Q Meng, D Valentini, M Rao, E Dodoo, M Maeurer |
Scientific Reports | 2018 |
Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells
E Muraro, A Merlo, D Martorelli, M Cangemi, SD Santa, R Dolcetti, A Rosato |
Frontiers in immunology | 2017 |
Epstein-Barr Virus as a Promising Immunotherapeutic Target for Nasopharyngeal Carcinoma Treatment
SY Teow, HY Yap, SC Peh |
Journal of Pathogens | 2017 |
Measurement of CD8+ and CD4+ T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCs
DH Sohn, HJ Sohn, HJ Lee, SD Lee, S Kim, SJ Hyun, HI Cho, SG Cho, SK Lee, TG Kim, JS Pagano |
PloS one | 2015 |
A complex role of herpes viruses in the disease process of multiple sclerosis
SC Wuest, I Mexhitaj, NR Chai, E Romm, J Scheffel, B Xu, K Lane, T Wu, B Bielekova |
PloS one | 2014 |
MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response
HM Long, OL Chagoury, AM Leese, GB Ryan, E James, LT Morton, RJ Abbott, S Sabbah, W Kwok, AB Rickinson |
Journal of Experimental Medicine | 2013 |
CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques
RM Leskowitz, XY Zhou, F Villinger, MH Fogg, A Kaur, PM Lieberman, F Wang, HC Ertl |
Journal of virology | 2013 |
Therapeutic vaccination against the rhesus lymphocryptovirus EBNA-1 homologue, rhEBNA-1, elicits T cell responses to novel epitopes in rhesus macaques
EL Silveira, MH Fogg, RM Leskowitz, HC Ertl, RW Wiseman, DH O'Connor, P Lieberman, F Wang, F Villinger |
Journal of virology | 2013 |
Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections
U Gerdemann, JM Keirnan, UL Katari, R Yanagisawa, AS Christin, LE Huye, SK Perna, S Ennamuri, S Gottschalk, MK Brenner, HE Heslop, CM Rooney, AM Leen |
Molecular Therapy | 2012 |
Enhancing cancer immunotherapy by intracellular delivery of cell-penetrating peptides and stimulation of pattern-recognition receptor signaling
HY Wang, RF Wang |
Advances in immunology | 2012 |
Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model
S Nair, W Bayer, MJ Ploquin, G Kassiotis, KJ Hasenkrug, U Dittmer |
Retrovirology | 2011 |
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
U Gerdemann, JF Vera, CM Rooney, AM Leen |
Journal of visualized experiments : JoVE | 2011 |
Prospects of a novel vaccination strategy for human gamma-herpesviruses
TT Wu, MA Blackman, R Sun |
Immunologic Research | 2010 |
Persistent γ-Herpesvirus Infection Induces a CD4 T Cell Response Containing Functionally Distinct Effector Populations
KA Stuller, SS Cush, E Flaño |
Journal of immunology (Baltimore, Md. : 1950) | 2010 |
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
C Gurer, T Strowig, F Brilot, M Pack, C Trumpfheller, F Arrey, CG Park, RM Steinman, C Münz |
Blood | 2008 |
Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma
T Strowig, F Brilot, F Arrey, G Bougras, D Thomas, WA Muller, C Münz |
PLoS pathogens | 2008 |
EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2
JD Lünemann, I Jelcić, S Roberts, A Lutterotti, B Tackenberg, R Martin, C Münz |
Journal of Experimental Medicine | 2008 |
The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression
PK Chattopadhyay, MR Betts, DA Price, E Gostick, H Horton, M Roederer, SC de Rosa |
Journal of leukocyte biology | 2008 |
Immune escape by Epstein-Barr virus associated malignancies
C Münz, A Moormann |
Seminars in Cancer Biology | 2008 |
Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis
JD Lünemann, P Huppke, S Roberts, W Brück, J Gärtner, C Münz |
Neurology | 2008 |
Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1
KN Heller, F Arrey, P Steinherz, C Portlock, A Chadburn, K Kelly, C Münz |
International Journal of Cancer | 2008 |
Increased Frequency of EBV-Specific Effector Memory CD8+ T Cells Correlates with Higher Viral Load in Rheumatoid Arthritis
Lünemann JD, Frey O, Eidner T, Baier M, Roberts S, Sashihara J, Volkmer R, Cohen JI, Hein G, Kamradt T, Münz C |
Journal of immunology (Baltimore, Md. : 1950) | 2008 |
Primary CD4+ T-Cell Responses Provide both Helper and Cytotoxic Functions during Epstein-Barr Virus Infection and Transformation of Fetal Cord Blood B Cells
GJ MacArthur, AD Wilson, MA Birchall, AJ Morgan |
Journal of virology | 2007 |
Epstein-Barr Virus: Environmental Trigger of Multiple Sclerosis?
JD Lünemann, T Kamradt, R Martin, C Münz |
Journal of virology | 2007 |
Acquisition of direct antiviral effector functions by CMV-specific CD4 + T lymphocytes with cellular maturation
JP Casazza, MR Betts, DA Price, ML Precopio, LE Ruff, JM Brenchley, BJ Hill, M Roederer, DC Douek, RA Koup |
Journal of Experimental Medicine | 2006 |
Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers
KN Heller, J Upshaw, B Seyoum, H Zebroski, C Münz |
Blood | 2006 |
Immune Regulation of Viral Infection and Vice Versa
HW Virgin |
Immunologic Research | 2005 |
Critical Role of EBNA1-Specific CD4+ T Cells in the Control of Burkitt’s Lymphoma in vivo
Tihui Fu, Kuishin Voo and Rong-Fu Wang |
Journal of Clinical Investigation | 2004 |
An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection
RL Sparks-Thissen, DC Braaten, S Kreher, SH Speck, HW 4th |
Journal of virology | 2004 |
Epstein-Barr Virus Nuclear Antigen 1: Figure 1.: from Immunologically Invisible to a Promising T Cell Target
C Münz |
Journal of Experimental Medicine | 2004 |
Identification of a Protective CD4 + T-Cell Epitope in p15 gag of Friend Murine Leukemia Virus and Role of the MA Protein Targeting the Plasma Membrane in Immunogenicity
D Sugahara, S Tsuji-Kawahara, M Miyazawa |
Journal of virology | 2004 |
Dendritic cells initiate immune control of epstein-barr virus transformation of B lymphocytes in vitro
K Bickham, K Goodman, C Paludan, S Nikiforow, ML Tsang, RM Steinman, C Münz |
Journal of Experimental Medicine | 2003 |
Cytolytic CD4 + -T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation
S Nikiforow, K Bottomly, G Miller, C Münz |
Journal of virology | 2003 |
In vitro cytokine production and growth inhibition of lymphoblastoid cell lines by CD4+ T cells from Epstein-Barr virus (EBV) seropositive donors
AD Wilson, JC Hopkins, AJ Morgan |
Clinical & Experimental Immunology | 2001 |
Multiple Effector Functions Mediated by Human Immunodeficiency Virus-Specific CD4 + T-Cell Clones
PJ Norris, M Sumaroka, C Brander, HF Moffett, SL Boswell, T Nguyen, Y Sykulev, BD Walker, ES Rosenberg |
Journal of virology | 2001 |
Differential Immunogenicity of Epstein-Barr Virus Latent-Cycle Proteins for Human CD4 + T-Helper 1 Responses
A Leen, P Meij, I Redchenko, J Middeldorp, E Bloemena, A Rickinson, N Blake |
Journal of virology | 2001 |
Dendritic Cells Cross-Present Latency Gene Products from Epstein-Barr Virus–Transformed B Cells and Expand Tumor-Reactive Cd8+ Killer T Cells
Subklewe M, Paludan C, Tsang ML, Mahnke K, Steinman RM, Münz C |
Journal of Experimental Medicine | 2001 |